Novartis division Sandoz recalls one lot of blood pressure drug
The drug is made by China’s Zhejiang Huahai Pharmaceutical
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Mylan and Theravance’s COPD treatment gets FDA approval
The treatment, Yupelri, is a once-daily inhalable solution to be used by patients of COPD
Glenmark to launch trial in solid tumours for its CD38xCD3 bispecific antibody GBR 1342
GBR 1342 is one of three investigational immuno-oncology agents based on Glenmark’s proprietary BEAT platform
Strides’ subsidiary inks pact with SUDA Pharmaceuticals for migraine drug
Under the terms of agreement, SUDA will receive an upfront cash payment of $ 0.4 million and a further payment of $ 0.6 million on…
IIT Roorkee researchers develop carbon nanomaterials for detection and destruction of cancer cells
With these promising observations, Dr Gopinath and his team are planning next stage animal studies for further evaluation of these…
Some factors have a greater impact on heart attack risk in women than they do in men: The BMJ
High blood pressure, smoking and diabetes increase heart attack risk more in women than in men
Lilly says diabetes drug Trulicity reduces heart risks in trial
The company did not provide any details on the magnitude of risk reduction seen in the so-called outcomes trial
bioLIVE to merge with BioProduction Congress for 2019 event
BioProduction’s content platform will be added to the bioLIVE exhibition, creating one of the world’s largest event hubs for the…
Sanofi and Regeneron’s Dupixent gets more positive feedback from US FDA
Dupixent was launched in the US in April 2017 for the treatment of moderate-to-severe eczema
The US Food & Drug…
Cipla posts ₹ 377 crore PAT in Q2FY19
The company's income from operations was at Rs 4012 crore